- Telehealth visits
- Insurance plan information
Julie Elis, PNP
She | Her | HersPediatric Hematology-Oncology- Telehealth visits
- Insurance plan information
Julie Elis, PNP
She | Her | HersPediatric Hematology-Oncology- Telehealth visits
- Insurance plan information
On this page
About me
Julie Elis is a pediatric nurse practitioner who specializes in caring for children with sickle cell disease (an inherited blood disorder). She helps develop comprehensive care plans with the goal of enabling patients to live full lives outside the hospital, and she supports young adults as they transition from pediatric to adult care.
Elis earned her master's degree in nursing at UCSF.
Elis has lived and worked in countries throughout sub-Saharan Africa, South Asia and Southeast Asia. She served as a peace corps volunteer in Namibia, where she provided HIV/AIDS education to young people. She has benefited tremendously from seeing the many ways people around the world thrive. This has helped her develop a nonjudgmental and individualized approach to care.
Education & training
Board certification
- Pediatric Nurse Practitioner, Pediatric Nursing Certification Board (PNCB)
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
- Pediatric Hematology-Oncology
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225442%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225442%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.